Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Campaigns To Counter Criticism as Fake-Drug Source

This article was originally published in PharmAsia News

Executive Summary

China is attempting to counter criticism it is the source of a flood of fake or shoddy drugs around the world. A deputy commissioner of the State FDA called a news conference to press the Chinese case that it exports quality drug products and that they are safe. He said China's 4,708 pharmaceutical companies are not responsible for counterfeit drugs. If any fake drugs are being produced in China, he said, they are from illegal companies. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071749

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel